Abstract
Profoundly B-cell-depleted patients can have prolonged severe acute respiratory syndrome coronavirus 2 infections with evidence of active viral replication, due to inability to mount an adequate humoral response to clear the virus. We present 3 B-cell-depleted patients with prolonged coronavirus disease 2019 infection who were successfully treated with a combination of casirivimab/imdevimab and remdesivir.
Original language | English (US) |
---|---|
Article number | ofac064 |
Journal | Open Forum Infectious Diseases |
Volume | 9 |
Issue number | 6 |
DOIs | |
State | Published - Jun 1 2022 |
Keywords
- B-cell-depleted
- monoclonal antibodies
- prolonged SARS-CoV-2
ASJC Scopus subject areas
- Infectious Diseases
- Oncology